INTRODUCTION
The prostanoids are oxygenated derivatives of C20 fatty acids, principally arachidonic acid. Five pathways of arachidonic acid metabolism are currently recognized, and prostanoids are the products of the first of these to be discovered, the cyclooxygenase pathway. There are two major classes of prostanoids, the prostaglandins (PGs) and the thromboxanes (Needleman et al, 1986) .
PGs have been shown to be widely distributed in the gastrointestinal (GI) tract. Both the mucosa and the muscle layer of the gut are capable of generating the major products of biotransformation of arachidonic acid via the cyclooxygenase pathway such as PGE2, PGF2α, PGI2, and thromboxanes (Bennet et al, 1968; Ferreira et al, 1976; LeDuc & Needdleman, 1979; Robert, 1981; Sanders, 1981; Sanders, 1984) . Among the rest, thromboxane A2 (TXA2) is well known to alter the GI activity. For example, TXA2 was reported to be a potent constrictor of human stomach, ileum and colon (Bennett et al, 1981) and of the rat gastric fundus (Bennett & Sanger, 1982) . However, it failed to contract guinea-pig ileum (Coleman et al, 1981) . While TXA2 induced the contraction or relaxation in mouse ileum, suggesting some species difference (Okada et al, 2000) .
Interstitial cells of Cajal (ICC) in most locations form gap junctions with muscle cells and also with each other (Daniel & Posey-Daniel, 1984; Zhou & Komuro, 1992; Berezin et al, 1994) . Indirect evidence suggests them, to be responsible for the generation of phasic contractions in GI tract (Thuneberg, 1982; Sanders, 1992) . ICC generate rhythmic oscillations in membrane potential known as pacemaker potentials and this generation is due to spontaneous inward currents called pacemaker currents (Koh et al, 1998; Thomsen et al, 1998) . ICC also form close contacts with nerve terminals (Berezin et al, 1988 , Torihashi et al, 1993 and express the receptors for, and respond to, a variety of neurotransmitters (Publicover et al, 1992; Shuttleworth et al, 1993; Young et al, 1993; Sternini et al, 1995; Portbury et al, 1996) . Consequently, ICC have also been proposed to act as intermediaries in transmission between neurons and muscle cells (Thuneberg, 1982; Sanders, 1992) . Recent evidence suggests that ICC may serve both functions.
There are many reports to indicate that TXA2 has function on intestinal motility by acting on smooth muscles, however no studies have so far been performed to determine the effects of TXA2 on electrical events in mouse ICC. Therefore, the purpose of our study was to investigate the effects of TXA2 on pacemaker activity in cultured ICC. 
METHODS

Preparation of cells and tissues
Balb/C mice (3∼7 days old) of either sex were anesthetized with ether and sacrificed by cervical dislocation. The small intestines from 1 cm below the pyloric ring to the cecum were removed and opened along the mesenteric border. The luminal contents were washed away with Krebs-Ringer bicarbonate solution. The tissues were pinned to the base of a Sylgard dish, and the mucosa was removed by sharp dissection. Small stripes of intestinal muscle were equilibrated in Ca 2+ -free Hank's solution for 30 min and the cells were dispersed with an enzyme solution containing 1.3 mg/ml collagenase (Worthington Biochemical Co, Lakewood, NJ, USA), 2 mg/ml bovine serum albumin (Sigma Chemical Co., St. Louis, MO, USA), 2 mg/ml trypsin inhibitor (Sigma) and 0.27 mg/ml ATP. Cells were plated onto sterile glass coverslips coated with murine collagen (2.5μg/ml, Falcon/BD) in 35 mm culture dishes. The cells were then cultured at 37 o C in a 95 % O2-5 % CO2 incubator in SMGM (smooth muscle growth medium, Clonetics Corp., San Diego, CA, USA) supplemented with 2% antibiotics/ antimycotics (Gibco, Grand Island, NY, USA) and murine stem cell factor (SCF, 5 ng/ml, Sigma). Interstitial cells of Cajal (ICC) were identified immunologically with a monoclonal antibody for Kit protein (ACK2) labelled with Alexa Fluor 488 (molecular Probe, Eugene, OR, USA).
Patch clamp experiments
The whole-cell configuration of the patch-clamp technique was used to record membrane currents (voltage clamp) and membrane potentials (current clamp) from cultured ICC. Currents or potentials were amplified by use of an Axopatch 1-D (Axon Instruments, Foster, CA, USA). Command pulse was applied using an IBM-compatible personal computer and pClamp software (version 6.1; Axon Instruments). The data were filtered at 5 kHz and displayed on an oscilloscope, a computer monitor, and a pen recorder (Gould 2200, Gould, Valley view, OH, USA).
Results were analyzed using pClamp and Sigma plot (version 9.0) software. All experiments were performed at 30 o C.
Solutions and drugs
The cells were bathed in a solution containing (mM): 5 mM KCl, 135 mM NaCl, 2 mM CaCl2, 10 mM glucose, 1.2 mM MgCl2, and 10 mM HEPES, pH adjusted to 7.2 with Fig. 2 . The effects of GDP-β-S in response to TXA2 induced pacemaker currents from ICC of mouse small intestine (A) Pacemaker currents from ICC exposed to TXA2 (5μM) in the presence of GDP-β-S (1 mM) in the pipette. The tonic inward currents with suppressed amplitudes and frequency induced by TXA2 were blocked by internally applied GDP-β-S (1 mM). The dotted lines indicate the zero current levels. The effects of TXA2 in the presence of GDP-β-S are summarized in (B). Vertical solid line scales amplitude of pacemaker current and horizontal solid line scales for duration of recording (s) pacemaker currents. Bars represent mean values ± SE. The effects of GDP-β-S on TXA2-induced pacemaker currents were significantly different from the TXA2-induced pacemaker currents (p ＜ 0.01). The bars represent mean values±SE. **Significantly different from the untreated control (Con) (p ＜ 0.01).
Tris. The pipette solution contained 140 mM KCl, 5 mM MgCl2, 2.7 mM K2ATP, 0.1 mM Na2GTP, 2.5 mM creatine phosphate disodium, 5 mM HEPES, 0.1 mM EGTA, pH adjusted to 7.2 with Tris.
Drugs used were: U-46619, guanosine 5'-[-thio]diphosphate trilithium salt (GDP-β-S), calphostin C, chelethrine, and thapsigargin. All drugs were purchased from Sigma Chemical Co (St. Louis, MO, USA).
Statistical analysis
Data are expressed as mean±standard error. Differences in the data were evaluated by Student's t test. A p-values less than 0.05 were taken as a statistically significant difference. The n-values reported in the text refer to the number of cells used in the patch-clamp experiments.
RESULTS
Effect of TXA2 on pacemaker potentials and currents in cultured ICC
ICC were identified with immunofluorescence using Kit antibody, and had a distinctive morphology easily recognizable in cultures. We performed the electrophysiological recording from cultured ICC under current (I=0) and voltage clamp mode. Under current clamp mode, ICC spontaneously showed pacemaker potentials. The resting membrane potential was -48±3 mV and amplitude was 25±6 mV. In the presence of U46619 (5μM), a thromboxane receptor agonist, membrane potentials were depolarized to -19±2.4 mV, and the amplitude of pacemaker potentials was decreased to 4.7±1.4 mV (n=5, Fig. 1A , bar graph not shown). These results suggested that ICC have the spontaneous pacemaker activity, and that U46619 has an effect on this electrical activity of ICC. Under a voltage clamp at a holding potential of -70 mV, the ICC generated spontaneous inward currents. Treatment of cultured ICC with various concentrations of U46619 (1, 3, and 5μM) produced tonic inward currents and decreased the frequency and the amplitude of pacemaker currents in a dose-dependent manner (Fig. 1B, C, and D) . As shown in Fig 1E, F, and G, the values of frequency, amplitude and resting currents about pacemaker currents in control condition were significantly different from those obtained in the presence of U46619 (3 and 5μM).
Involvement of G proteins in the TXA2-induced tonic inward currents in cultured ICC
The effects of GDP-β-S, a nonhydrolysable guanosine 5'-diphosphate analogue which permanently inactivates GTP binding proteins, were examined to determine whether the G-protein is involved in the effects of TXA2 on ICC. When GDP-β-S (1 mM) was in the pipette, U46619 (5μM) did not show the tonic inward currents (Fig. 2A) . In the presence of GDP-β-S in the pipette, the resting currents in control were -19±8 pA. The resting currents by treatment with U46619 in the presence of GDP-β-S were -22.6±5 pA (n = 4, Fig. 2B ), which were significantly different from those obtained by treatment with U46619 in the absence of GDP-β-S. -free solution completely inhibited the pacemaker currents in voltage clamp mode at a holding potential of -70 mV, and U46619 (5μM)-induced effects on pacemaker currents in this condition were blocked (n=5, Fig. 3A) . The value of resting currents with U46619 (5μM) in Ca 2+ -free solution was significantly different, compared with control value obtained in normal solution (Fig. 3B) . In addition, the treatment of thapsigargin (5μM) inhibited the pacemaker currents in ICC and blocked the U46619-induced tonic inward currents (Fig. 3C ). In the presence of thapsigargin, the value of resting currents by treatment with U46619 was significantly different from those obtained by treatment with U46619 in the absence of thapsigargin (n=6, Fig. 3D ).
External
Effects of protein kinase C inhibitor on TXA2 -induced responses in cultured ICC
We tested the effects of chelerythrine or calphostin C, an inhibitor of protein kinase C (PKC), to investigate whether TXA2-induced responses to pacemaker currents are mediated by the activation of PKC. Chelerythrine (1μM) or calphostin C (0.1μM) did not have an effect on tonic inward currents by U46619 (5μM) (Fig. 4A and C) , and the value was not also significantly different, compared with the tonic inward currents by U46619 obtained in the absence of chelerythrine or calphostin C (n=5, Fig. 4B and D) .
DISCUSSION
Although the effects TXA2 on the intestinal motility in tissue and smooth muscle cells have amply been demonstrated, this is the first study to determine the effects of TXA2 on electrical activity in small intestine.
Present results demonstrate that TXA2 regulates intestinal motility by modulating the pacemaker currents of ICC, and that this modulation is mediated via acting on G protein and extra-and intracellular Ca 2+ mobilization in a PKC-independent manner.
While contractile actions of TXA2 on airway and vascular smooth muscles are well known, those on smooth muscle of gastrointestinal tract have not yet been fully characterized. Also, TXA2 have some species difference in GI tract. Recently, it was suggested that TXA2 has strong contractile actions on both the fundus and ileum, which were mediated mainly via the thromboxane receptors in mice (Okada, 2000) . Moreover, the above study showed that TXA2 has the highest potency among the prostaglandin E2, D2, I2, and F2α, suggesting physiological or pathophysiological roles of TXA2 played in the direct or indirect actions on gastrointestinal smooth muscles, which has largely been attributed to its action on vasculature and blood platelets. Namely, the above study indicates the possibility that TXA2 may have stimulatory or inhibitory functions on electrical activity of ICC. In the present study, we observed that TXA2 evoked the depolarization of pacemaker potentials and tonic inward currents of pacemaker currents in ICC, implying that the regulation of electrical activity in ICC may be involved in the contractile effects of TXA2 in intestinal tract.
TXA2 induces the effects by increasing the cytosolic Ca 2+ concentration which is independent of extracellular Ca
2+
and does not involve changes in inositol (1,4,5) trisphosphate (IP3) levels, suggesting that this TXA2 action involves mobilization of Ca 2+ from intracellular stores via an IP3-independent process in platelet (Nakano et al, 1988; Arita et al, 1989) . And many reports suggested that TXA2 leads to phospholipase C (PLC) activation, indicating that TXA2 receptors are coupled in part to a pertussis toxininsensitive G protein (Pollock et al, 1984; Watson et al, 1985; Brass et al, 1987; Sage & Rink, 1987; Siess et al, 1986; Shenker et al, 1991) . Overall, these studies suggest that TXA2 receptors couple directly to G protein, resulting in PLC activation, IP3-dependent Ca 2+ mobilization, and activation of PKC activation through diglyceride formation, further coupling TXA2 receptors to a second G protein. It is not clear whether coupling to the G protein is involved in IP3-independent Ca 2+ mobilization and/or a Ca 2+ channel that mediates the entry of extracellular Ca
. In this study, the tonic inward currents of pacemaker currents were blocked by TXA2, when GDPβS was present in the pipette. This means that the effects of TXA2 on electrical activity in ICC may be related with G proteins. Because many suggestions have been made that TXA2 may have biological activity through mobilization of intracellular Ca 2+ , we used thapsigargin, a potent endoplasmic reticulum Ca 2+ -ATPase inhibitor, and found that those inhibitors suppressed the TXA2-induced tonic inward currents. These results strongly suggest that the release of Ca 2+ from internal storage by TXA2 is essential to produce tonic inward currents, in correspondence with previous suggestions. In addition, it is well known that the generation of pacemaker currents is dependent upon intracellular Ca 2+ oscillation and the periodic release of Ca 2+ from endoplasmic reticulum is essential for generation of pacemaker currents. Also, in the present study, chelerythrine or calphostin C, specific and potent PKC inhibitors, did not block TXA2-induced effects, suggesting that PKC is not involved on the actions of TXA2 in ICC.
In conclusion, this study describes the effects of TXA2 on ICC in the mouse small intestine. TXA2 depolarized the membrane with increased tonic inward currents, which was via external Ca 2+ influx and internal Ca 2+ mobilization in a PKC-independent manner. Thus, the action of TXA2 on ICC may explain the excitatory action of TXA2 in GI motility.
